Makers Laboratories Ltd
MAKERSLMakers Laboratories Ltd
MAKERSL
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 20.72 | 1.00 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Makers Laboratories is engaged in the pharmaceuticals business. It's product portfolio covers a range of general health therapeutic segments
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 69.60 | 129.84 | 103.56 | 105.92 | 125.29 | |||||
Raw Materials | 30.92 | 51.91 | 45.62 | 52.74 | 109.31 | |||||
| Power & Fuel Cost | 5.55 | 8.78 | 12.70 | 11.32 | ||||||
| Employee Cost | 8.71 | 12.51 | 11.73 | 13.94 | ||||||
| Selling & Administrative Expenses | 6.64 | 10.22 | 8.54 | 9.05 | ||||||
| Operating & Other expenses | 8.70 | 24.97 | 19.36 | 16.23 | ||||||
EBITDA | 9.08 | 21.45 | 5.61 | 2.64 | 15.98 | |||||
| Depreciation/Amortization | 4.61 | 4.02 | 4.24 | 4.54 | 4.88 | |||||
| PBIT | 4.47 | 17.43 | 1.37 | -1.90 | 11.10 | |||||
| Interest & Other Items | 1.76 | 1.74 | 2.20 | 2.02 | 1.97 | |||||
| PBT | 2.71 | 15.69 | -0.83 | -3.92 | 9.13 | |||||
| Taxes & Other Items | 3.04 | 10.71 | 3.91 | 2.34 | 4.11 | |||||
| Net Income | -0.33 | 4.98 | -4.74 | -6.26 | 5.02 | |||||
| EPS | -0.64 | 9.92 | -8.76 | -10.61 | 8.51 | |||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Makers Laboratories Ltd | -16.62 | 1.00 | — |
| Sun Pharmaceutical Industries Ltd | 45.35 | 6.47 | 0.75% |
| Cipla Ltd | 28.51 | 4.38 | 0.89% |
| Torrent Pharmaceuticals Ltd | 68.45 | 16.54 | 0.84% |
Price Comparison
Compare MAKERSL with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.09%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
MAKERSL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 1, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Aug 1, 2019
Cash Dividend
Ex DateEx DateJul 26, 2018
Dividend/Share
₹1.00
Ex DateEx Date
Jul 26, 2018
Cash Dividend
Ex DateEx DateJul 20, 2017
Dividend/Share
₹1.00
Ex DateEx Date
Jul 20, 2017
Cash Dividend
Ex DateEx DateAug 2, 2016
Dividend/Share
₹1.00
Ex DateEx Date
Aug 2, 2016
Cash Dividend
Ex DateEx DateJul 28, 2015
Dividend/Share
₹1.00
Ex DateEx Date
Jul 28, 2015
Net profit of Makers Laboratories reported to Rs 8.82 crore in the quarter ended September 2024 as against net loss of Rs 1.34 crore during the previous quarter ended September 2023. Sales rose 18.00% to Rs 29.57 crore in the quarter ended September 2024 as against Rs 25.06 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales29.5725.06 18 OPM %7.370.80 - PBDT12.270.12 10125 PBT10.97-1.02 LP NP8.82-1.34 LP Powered by Capital Market - Live
Makers Laboratories will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live
Makers Laboratories reports consolidated net loss of Rs 0.98 crore in the June 2024 quarter
Net Loss of Makers Laboratories reported to Rs 0.98 crore in the quarter ended June 2024 as against net loss of Rs 2.10 crore during the previous quarter ended June 2023. Sales rose 18.31% to Rs 29.59 crore in the quarter ended June 2024 as against Rs 25.01 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales29.5925.01 18 OPM %6.12-0.52 - PBDT1.70-0.30 LP PBT0.42-1.40 LP NP-0.98-2.10 53 Powered by Capital Market - Live
Makers Laboratories will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live
Makers Laboratories reports consolidated net loss of Rs 0.64 crore in the September 2022 quarter
Makers Laboratories reports consolidated net loss of Rs 0.61 crore in the March 2022 quarter
Board of Makers Laboratories approves right issue of Rs 14.75 cr
Makers Laboratories standalone net profit declines 13.83% in the September 2021 quarter
Makers Laboratories standalone net profit rises 1400.00% in the June 2021 quarter
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant